This HTML5 document contains 34 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://linked.opendata.cz/resource/drugbank/drug/DB08969/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08969
rdf:type
n3:Drug
n3:description
Flurothyl is a convulsant primarily used in experimental animals. It was formerly used to induce convulsions as a alternative to electroshock therapy.
n3:group
withdrawn
owl:sameAs
n6:DB08969
dcterms:title
Flurothyl
adms:identifier
n8:DB08969
n3:synthesisReference
U.S. Patent 3,661,903.
n3:IUPAC-Name
n4:271B60CA-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B60D0-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B60CF-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B60CC-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B60CD-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B60CE-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B60C8-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B60C6-363D-11E5-9242-09173F13E4C5 n4:271B60C9-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B60C7-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B60D6-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B60D7-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B60D1-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B60D2-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B60D4-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B60D3-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B60D5-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
333-36-8
n3:Bioavailability
n4:271B60DB-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B60DD-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B60DE-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B60DF-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B60DA-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B60D9-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B60DC-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B60CB-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B60D8-363D-11E5-9242-09173F13E4C5